Skip to content

Clinical Observation of Dry-needling and Combined with Intradermal in the Treatment of PHN

Clinical Observation of Dry-needling and Combined with Intradermal in the Treatment of PHN

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100052586
Enrollment
Unknown
Registered
2021-10-31
Start date
2019-01-20
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post-herpetic Neuralgia

Interventions

Dry-needling group:Dry-needling
Drug treatment group:Drug

Sponsors

Guangdong Provincial People's Zhuhai Hospital(Zhuhai Golden Bay Center Hospital)
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Patients diagnosed with PHN without nerve block; 2. Aged from 18 to 80 years; 3. There is no deformity in the body and no infection in the skin of the whole body; 4. Willing to accept the study and sign the study consent form.

Exclusion criteria

Exclusion criteria: 1. ASA grade 3 or more, such as severe cardiovascular and cerebrovascular disease, uncontrolled diabetes, etc; 2. Patients with sensory abnormalities caused by mental disorders and/or neuropathy; 3. Patients with a history of study drug allergy; 4. Patients with severe abnormal coagulation function; 5. Patients who cannot cooperate with the questionnaire.

Design outcomes

Primary

MeasureTime frame
Visual analogue scale;

Secondary

MeasureTime frame
Tip glucose;

Countries

China

Contacts

Public ContactHuang Yifa

Guangdong Provincial People's Hospital Zhuhai Hospital, Zhuhai Golden Bay Center Hospital

42955530@qq.com+86 18902886996

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026